GLUL and Alzheimer disease: Reductions in glutamine synthesis arise during the very early phases of disease progression in the 3xTG mouse model of Alzheimer's disease (Kulijewicz‐Nawrot et al. 2013), suggesting that GS dysfunction is a critical early pathological feature.